Bo Tang

511 citations
17 papers · 390 indexed · h-index 11
Topics
Cancer Research and Treatments (9 papers)Nanoplatforms for cancer theranostics (7 papers)Virus-based gene therapy research (5 papers)

In The Last Decade

Bo Tang

15 papers receiving 389 citations

Peers

Bo Tang
Comparison fields: 5 of 63
  • Biotechnology 221
  • Biomedical Engineering 183
  • Molecular Biology 102
  • Genetics 98
  • Immunology 76
Replace Thuy Phan with:
Thuy Phan United States
Rosa L. Vincent United States
Shiyu Song China
Søren Carlsen Denmark
Jiahong Chen China
Hans‐Dieter Pohl Germany
Xiangdong Ma China
Steven Szarka Canada
Nastaran Barati Iran
Abdul Qader Abbady Syria
Bo Tang relative to Thuy Phan United States Thuy Phan's profile →
Citations per field
00.5×1.5×2.2×
Thuy Phan · 1×
Citations per year

Countries citing papers authored by Bo Tang

Since Specialization
Citations

This map shows the geographic impact of Bo Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Tang more than expected).

Fields of papers citing papers by Bo Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Tang. The network helps show where Bo Tang may publish in the future.

Co-authorship network of co-authors of Bo Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Tang. A scholar is included among the top collaborators of Bo Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Tang. Bo Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 49
5 38
6 1
7 60
8 19
9 9
10 17
11 33
12
[Influence of CO2 pneumoperitoneum pressures on the expression of adhesion molecules of gastric cancer cells].
3
13 50
14 28
15 21
16 39
17
Expression and purification of intact and functional soybean (Glycine max) seed ferritin complex in Escherichia coli.
22

About Bo Tang

Bo Tang is a scholar working on Biotechnology, Cancer Research and Physiology, having authored 17 papers that have together received 390 indexed citations. Recurring topics across this work include Cancer Research and Treatments (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Biotechnology (221 citations), Biomedical Engineering (183 citations) and Immunology (76 citations). Bo Tang has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Zichun Hua, Jianxiang Chen, Guo Chen, Yiting Qiao, Xiufeng Liu, Xiawei Cheng, Bingya Yang, Wenhui Jiang, Qingang Hu and Xiangyu Zhang. Their work appears in journals such as Journal of Clinical Oncology, Coordination Chemistry Reviews and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026